APA

Dominick M. A., White M. R., Sanderson T. P., Van Vleet T., Cohen S. M., Arnold L. E., Cano M., Tannehill-Gregg S., Moehlenkamp J. D., Waites C. R. & Schilling B. E. (20070123). Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action. : Toxicologic pathology.

Chicago

Dominick Mark A, White Melvin R, Sanderson Thomas P, Van Vleet Terry, Cohen Samuel M, Arnold Lora E, Cano Marty, Tannehill-Gregg Sarah, Moehlenkamp Jeffrey D, Waites Crystal R and Schilling Beth E. 20070123. Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action. : Toxicologic pathology.

Harvard

Dominick M. A., White M. R., Sanderson T. P., Van Vleet T., Cohen S. M., Arnold L. E., Cano M., Tannehill-Gregg S., Moehlenkamp J. D., Waites C. R. and Schilling B. E. (20070123). Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action. : Toxicologic pathology.

MLA

Dominick Mark A, White Melvin R, Sanderson Thomas P, Van Vleet Terry, Cohen Samuel M, Arnold Lora E, Cano Marty, Tannehill-Gregg Sarah, Moehlenkamp Jeffrey D, Waites Crystal R and Schilling Beth E. Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action. : Toxicologic pathology. 20070123.